FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

garret fitzgerald

Research Profile

Chemicals & Drugs

Disorders

Procedures

Gas Chromatography-Mass Spectrometry

Co-author Network

Publications

TOP 3
M T Olson; garret fitzgerald; J Jani; Thomas S Kickler; J A Lawson; Rhondalyn CLAUDINA McLean; Jeffrey J Rade
Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.
C Skarke; N Alamuddin; L Cen; J A Lawson; K J Propert; garret fitzgerald
Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649.
garret fitzgerald
Regulatory science: what it is and why we need it.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of garret fitzgerald (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: M T Olson; garret fitzgerald; J Jani; Thomas S Kickler; J A Lawson; Rhondalyn CLAUDINA McLean; Jeffrey J Rade
Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk.
Journal of thrombosis and haemostasis : JTH 2012;10(12):2462-9.
2012: C Skarke; N Alamuddin; L Cen; J A Lawson; K J Propert; garret fitzgerald
Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649.
Clinical pharmacology and therapeutics 2012;91(6):986-93.
2011: garret fitzgerald
Regulatory science: what it is and why we need it.
Clinical pharmacology and therapeutics 2011;89(2):291-4.
2009: Chih-Tsung Chang; Pranav Patel; Vivek Gore; Wen-Liang Song; John A Lawson; William S Powell; garret fitzgerald; Joshua Rokach
A new approach to the synthesis of polyunsaturated deuterated isoprostanes: total synthesis of d4-5-epi-8,12-iso-iPF3alpha-VI and d4-8,12-iso-iPF3alpha-VI.
Bioorganic & medicinal chemistry letters 2009;19(23):6755-8.
2009: Andrew O Maree; garret fitzgerald
A roadmap for the twilight zone: navigating United States cardiovascular career development for international trainees.
Circulation 2009;120(15):1542-9.
2009: Wen-Liang Song; Georgios Paschos; Susanne Fries; Muredach P Reilly; Ying Yu; Joshua Rokach; Chih-Tsung Chang; Pranav Patel; John A Lawson; garret fitzgerald
Novel eicosapentaenoic acid-derived F3-isoprostanes as biomarkers of lipid peroxidation.
The Journal of biological chemistry 2009;284(35):23636-43.
2009: Etty Grad; M Golomb; N Koroukhov; J A Lawson; Chaim Lotan; garret fitzgerald; H D Danenberg
Aspirin reduces the prothrombotic activity of C-reactive protein.
Journal of thrombosis and haemostasis : JTH 2009;7(8):1393-400.
2009: Doron C Greenbaum; garret fitzgerald
Platelets, pyrexia, and plasmodia.
The New England journal of medicine 2009;361(5):526-8.
2009: Y Yu; E Ricciotti; Tilo Grosser; garret fitzgerald
The translational therapeutics of prostaglandin inhibition in atherothrombosis.
Journal of thrombosis and haemostasis : JTH 2009;7 Suppl 1():222-6.
2009: Ying Yu; Margaret B Lucitt; Jane Stubbe; Yan Cheng; Ulla G Friis; Pernille B Hansen; Boye L Jensen; Emer M Smyth; garret fitzgerald
Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(19):7985-90.
2009: Dairong Wang; Vickas V Patel; Emanuela Ricciotti; Rong Zhou; Mark David Levin; Ehre Gao; Zhou Yu; Victor A Ferrari; Min Min Lu; Junwang Xu; Hualei Zhang; Yiqun Hui; Yan Cheng; Nataliya Petrenko; Ying Yu; garret fitzgerald
Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(18):7548-52.
2009: Emer M Smyth; Tilo Grosser; Miao Wang; Ying Yu; garret fitzgerald
Prostanoids in health and disease.
Journal of lipid research 2009;50 Suppl():S423-8.
2009: Julie E Baggs; Tom S Price; Luciano DiTacchio; Satchidananda Panda; garret fitzgerald; John B Hogenesch
Network features of the mammalian circadian clock.
PLoS biology 2009;7(3):e52.
2009: Daniel Vardeh; Dairong Wang; Michael Costigan; Michael Lazarus; Clifford B Saper; Clifford J Woolf; garret fitzgerald; Tarek A Samad
COX2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice.
The Journal of clinical investigation 2009;119(2):287-94.
2008: Ioannis Parastatidis; Leonor Thomson; Anne Burke; Irina Chernysh; Chandrasekaran Nagaswami; Jetze Visser; Sheryl Stamer; Daniel C Liebler; George Koliakos; Harry F G Heijnen; garret fitzgerald; John W Weisel; Harry Ischiropoulos
Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor.
The Journal of biological chemistry 2008;283(49):33846-53.
2008: Tom S Price; Julie E Baggs; Anne M Curtis; garret fitzgerald; John B Hogenesch
WAVECLOCK: wavelet analysis of circadian oscillation.
Bioinformatics (Oxford, England) 2008;24(23):2794-5.
2008: Chih-Tsung Chang; Pranav Patel; Namin Kang; John A Lawson; Wen-Liang Song; William S Powell; garret fitzgerald; Joshua Rokach
Eicosapentaenoic-acid-derived isoprostanes: synthesis and discovery of two major isoprostanes.
Bioorganic & medicinal chemistry letters 2008;18(20):5523-7.
2008: garret fitzgerald
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA : the journal of the American Medical Association 2008;300(8):900-1; author reply 904-5.
2008: garret fitzgerald
Drugs, industry, and academia.
Science (New York, N.Y.) 2008;320(5883):1563.
2008: Mei Chen; Eric Boilard; Peter A Nigrovic; Patsy Clark; Daigen Xu; garret fitzgerald; Laurent P Audoly; David M Lee
Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis.
Arthritis and rheumatism 2008;58(5):1354-65.
2008: Miao Wang; Wen-Liang Song; Yan Cheng; garret fitzgerald
Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease.
Journal of internal medicine 2008;263(5):500-5.
2008: Margaret B Lucitt; Thomas S Price; Angel Pizarro; Weichen Wu; Anastasia K Yocum; Christoph Seiler; Michael Pack; Ian A Blair; garret fitzgerald; Tilo Grosser
Analysis of the zebrafish proteome during embryonic development.
Molecular & cellular proteomics : MCP 2008;7(5):981-94.
2008: Bonnie Ky; Anne Burke; Sotirios Tsimikas; Megan L Wolfe; Mahlet G Tadesse; Philippe Szapary; Joseph L Witztum; garret fitzgerald; Daniel J Rader
The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
Journal of the American College of Cardiology 2008;51(17):1653-62.
2008: Elizabeth J Westgate; Yan Cheng; Dermot Reilly; Thomas S Price; Jacqueline A Walisser; Christopher A Bradfield; garret fitzgerald
Genetic components of the circadian clock regulate thrombogenesis in vivo.
Circulation 2008;117(16):2087-95.
2008: Takeshige Kunieda; Tohru Minamino; Kentaro Miura; Taro Katsuno; Kaoru Tateno; Hideyuki Miyauchi; Shuichi Kaneko; Christopher A Bradfield; garret fitzgerald; Issei Komuro
Reduced nitric oxide causes age-associated impairment of circadian rhythmicity.
Circulation research 2008;102(5):607-14.
2008: Miao Wang; Eric Lee; Wenliang Song; Emanuela Ricciotti; Daniel J Rader; John A Lawson; Ellen Puré; garret fitzgerald
Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation.
Circulation 2008;117(10):1302-9.
2008: garret fitzgerald
Translational therapeutics at the platelet vascular interface. Summary.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):s51-2.
2008: garret fitzgerald
Translational therapeutics at the platelet vascular interface. Introduction.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(3):s3-4.
2008: Wen-Liang Song; Miao Wang; Emanuela Ricciotti; Susanne Fries; Ying Yu; Tilo Grosser; Muredach Reilly; John A Lawson; garret fitzgerald
Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans.
The Journal of biological chemistry 2008;283(2):1179-88.
2008: Wen-Liang Song; John A Lawson; Dermot Reilly; Joshua Rokach; Chih-Tsung Chang; Benoit I Giasson; garret fitzgerald
Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid.
The Journal of biological chemistry 2008;283(1):6-16.
2008: Brendan J Keating; Sam Tischfield; Sarah S Murray; Tushar Bhangale; Thomas S Price; Joseph T Glessner; Luana Galver; Jeffrey C Barrett; Struan F A Grant; Deborah N Farlow; Hareesh R Chandrupatla; Mark Hansen; Saad Ajmal; George J Papanicolaou; Yiran Guo; Mingyao Li; Stephanie Derohannessian; Paul I W de Bakker; Swneke D Bailey; Alexandre Montpetit; Andrew C Edmondson; Kent Taylor; Xiaowu Gai; Susanna S Wang; Myriam Fornage; Tamim Shaikh; Leif Groop; Michael Boehnke; Alistair Hall; Andrew T Hattersley; Edward Frackelton; Nick Patterson; Charleston W K Chiang; Cecelia E Kim; Richard R Fabsitz; Willem Ouwehand; Alkes L Price; Patricia Munroe; Mark Caulfield; Thomas Drake; Eric Boerwinkle; David Reich; A Stephen Whitehead; Thomas P Cappola; Nilesh J Samani; A Jake Lusis; Eric Schadt; James G Wilson; Wolfgang Koenig; Mark I McCarthy; Sekar Kathiresan; Stacey B Gabriel; Hakon Hakonarson; Sonia S Anand; Muredach Reilly; James C Engert; Deborah A Nickerson; Daniel J Rader; Joel N Hirschhorn; garret fitzgerald
Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies.
PloS one 2008;3(10):e3583.
2008: Dermot Reilly; Anne M Curtis; Yan Cheng; Elizabeth J Westgate; Radu Daniel Rudic; Georgios Paschos; Jacqueline Morris; Ming Ouyang; Steven A Thomas; garret fitzgerald
Peripheral circadian clock rhythmicity is retained in the absence of adrenergic signaling.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(1):121-6.
2007: Colin D Funk; garret fitzgerald
COX-2 inhibitors and cardiovascular risk.
Journal of cardiovascular pharmacology 2007;50(5):470-9.
2007: Zeina Jaffar; Maria E Ferrini; Mary C Buford; garret fitzgerald; Kevan Roberts
Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ Th2 cells into the airways in a mouse model of asthma.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(9):6193-203.
2007: Jaou-Chen Huang; W-S A Wun; Jennifer S Goldsby; Karine Egan; garret fitzgerald; Kenneth K Wu
Prostacyclin receptor signaling and early embryo development in the mouse.
Human reproduction (Oxford, England) 2007;22(11):2851-6.
2007: Masayuki Wada; Cynthia J DeLong; Yu H Hong; Caroline Jill Rieke; Inseok Song; Ranjinder Sidhu; Chong Yuan; Mark Warnock; Alvin H Schmaier; Chieko Yokoyama; Emer M Smyth; Stephen J Wilson; garret fitzgerald; R Michael Garavito; De Xin Sui; John W Regan; William L Smith
Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products.
The Journal of biological chemistry 2007;282(31):22254-66.
2007: Dermot Reilly; Elizabeth J Westgate; garret fitzgerald
Peripheral circadian clocks in the vasculature.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(8):1694-705.
2007: garret fitzgerald
COX-2 in play at the AHA and the FDA.
Trends in pharmacological sciences 2007;28(7):303-7.
2007: Wen-Ling Chou; Lee-Ming Chuang; Chi-Chi Chou; Andrew H-J Wang; John A Lawson; garret fitzgerald; Zee-Fen Chang
Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation.
The Journal of biological chemistry 2007;282(25):18162-72.
2007: Trista E North; Wolfram Goessling; Carl R Walkley; Claudia Lengerke; Kamden R Kopani; Allegra M Lord; Gerhard J Weber; Teresa V Bowman; Il-Ho Jang; Tilo Grosser; garret fitzgerald; George Q Daley; Stuart H Orkin; Leonard I Zon
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis.
Nature 2007;447(7147):1007-11.
2007: Luis Alberto García Rodríguez; Karine Egan; garret fitzgerald
Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction?
PLoS medicine 2007;4(5):e157.
2007: Thomas S Price; Margaret B Lucitt; Weichen Wu; David J Austin; Angel Pizarro; Anastasia K Yocum; Ian A Blair; garret fitzgerald; Tilo Grosser
EBP, a program for protein identification using multiple tandem mass spectrometry datasets.
Molecular & cellular proteomics : MCP 2007;6(3):527-36.
2007: Weisong Zhou; Timothy S Blackwell; Kasia Goleniewska; Jamye F O'Neal; garret fitzgerald; Margaret Lucitt; Richard M Breyer; R Stokes Peebles
Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells.
Journal of leukocyte biology 2007;81(3):809-17.
2007: Anne M Curtis; Yan Cheng; Shiv Kapoor; Dermot Reilly; Thomas S Price; garret fitzgerald
Circadian variation of blood pressure and the vascular response to asynchronous stress.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3450-5.
2007: Weisong Zhou; Koichi Hashimoto; Kasia Goleniewska; Jamye F O'Neal; Shaoquan Ji; Timothy S Blackwell; garret fitzgerald; Karine M Egan; Mark W Geraci; R Stokes Peebles
Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(2):702-10.
2007: Ying Yu; Jinjin Fan; Yiqun Hui; Carol A Rouzer; Lawrence J Marnett; Andres J P Klein-Szanto; garret fitzgerald; Colin D Funk
Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality.
The Journal of biological chemistry 2007;282(2):1498-506.
2007: Wen-Liang Song; John A Lawson; Miao Wang; Helen Zou; garret fitzgerald
Noninvasive assessment of the role of cyclooxygenases in cardiovascular health: a detailed HPLC/MS/MS method.
Methods in enzymology 2007;433():51-72.
2007: garret fitzgerald
Clinical pharmacology or translational medicine and therapeutics: reinvent or rebrand and expand?
Clinical pharmacology and therapeutics 2007;81(1):19-20.
2006: Christopher P Cannon; Sean P Curtis; garret fitzgerald; Henry Krum; Amarjot Kaur; James A Bolognese; Alise S Reicin; Claire Bombardier; Michael E Weinblatt; Désirée van der Heijde; Erland Erdmann; Loren Laine
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Lancet 2006;368(9549):1771-81.
2006: John A Lawson; Seongjin Kim; William S Powell; garret fitzgerald; Joshua Rokach
Oxidized derivatives of omega-3 fatty acids: identification of IPF3 alpha-VI in human urine.
Journal of lipid research 2006;47(11):2515-24.
2006: Miao Wang; Alicia Zukas; Yiqun Hui; Emanuela Ricciotti; Ellen Puré; garret fitzgerald
Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(39):14507-12.
2006: Alysia Kern Lovgren; Leigh A Jania; John M Hartney; Kelly K Parsons; Laurent P Audoly; garret fitzgerald; Stephen L Tilley; Beverly H Koller
COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis.
American journal of physiology. Lung cellular and molecular physiology 2006;291(2):L144-56.
2006: Ying Yu; Jinjin Fan; Xin-Sheng Chen; Dairong Wang; Andres J P Klein-Szanto; Robert L Campbell; garret fitzgerald; Colin D Funk
Genetic model of selective COX2 inhibition reveals novel heterodimer signaling.
Nature medicine 2006;12(6):699-704.
2006: Yan Cheng; Miao Wang; Ying Yu; John Lawson; Colin D Funk; garret fitzgerald
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.
The Journal of clinical investigation 2006;116(5):1391-9.
2006: Sheila H Jacobo; Chih-Tsung Chang; Gue-Jae Lee; John A Lawson; William S Powell; Domenico Pratico'; garret fitzgerald; Joshua Rokach
Total synthesis of 8,12-iso-iPF3alpha-VI, an EPA-derived isoprostane: stereoselective introduction of the fifth asymmetric center.
The Journal of organic chemistry 2006;71(4):1370-9.
2006: Peng Y Woon; Anne M Curtis; Pamela J Kaisaki; Karène Argoud; Karin J Wallace; Marie-Thérèse Bihoreau; garret fitzgerald; Dominique Gauguier
Genomic organization of the rat Clock gene and sequence analysis in inbred rat strains.
Genomics 2006;87(2):208-17.
2006: Ferhana Y Ali; Karine Egan; garret fitzgerald; Béatrice Desvergne; Walter Wahli; David Bishop-Bailey; Timothy D Warner; Jane A Mitchell
Role of prostacyclin versus peroxisome proliferator-activated receptor beta receptors in prostacyclin sensing by lung fibroblasts.
American journal of respiratory cell and molecular biology 2006;34(2):242-6.
2006: Anne M Curtis; garret fitzgerald
Central and peripheral clocks in cardiovascular and metabolic function.
Annals of medicine 2006;38(8):552-9.
2006: Karine Egan; garret fitzgerald
Eicosanoids and the vascular endothelium.
Handbook of experimental pharmacology 2006;(176 Pt 1):189-211.
2006: Susanne Fries; Tilo Grosser; Thomas S Price; John A Lawson; Shiv Kapoor; Susan DeMarco; Mathew Pletcher; Timothy Wiltshire; garret fitzgerald
Marked interindividual variability in the response to selective inhibitors of cyclooxygenase-2.
Gastroenterology 2006;130(1):55-64.
2006: Tilo Grosser; Susanne Fries; garret fitzgerald
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.
The Journal of clinical investigation 2006;116(1):4-15.
2005: Radu Daniel Rudic; Peter McNamara; Dermot Reilly; Tilo Grosser; Anne M Curtis; Thomas S Price; Satchidananda Panda; John B Hogenesch; garret fitzgerald
Bioinformatic analysis of circadian gene oscillation in mouse aorta.
Circulation 2005;112(17):2716-24.
2005: garret fitzgerald
Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
Nature reviews. Drug discovery 2005;4(10):815-8.
2005: Helene Francois; Krairerk Athirakul; David Howell; Rajesh Dash; Lan Mao; Hyung-Suk Kim; Howard A Rockman; garret fitzgerald; Beverly H Koller; Thomas M Coffman
Prostacyclin protects against elevated blood pressure and cardiac fibrosis.
Cell metabolism 2005;2(3):201-7.
2005: Elizabeth J Westgate; garret fitzgerald
Pulmonary embolism in a woman taking oral contraceptives and valdecoxib.
PLoS medicine 2005;2(7):e197.
2005: Radu Daniel Rudic; Derek Brinster; Yan Cheng; Susanne Fries; Wen-Liang Song; Sandra Austin; Thomas M Coffman; garret fitzgerald
COX-2-derived prostacyclin modulates vascular remodeling.
Circulation research 2005;96(12):1240-7.
2005: Dairong Wang; Dairong Wong; Miao Wang; Yan Cheng; garret fitzgerald
Cardiovascular hazard and non-steroidal anti-inflammatory drugs.
Current opinion in pharmacology 2005;5(2):204-10.
2005: Ying Yu; Yan Cheng; Jinjin Fan; Xin-Sheng Chen; Andres Klein-Szanto; garret fitzgerald; Colin D Funk
Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition.
The Journal of clinical investigation 2005;115(4):986-95.
2005: Seongjin Kim; William S Powell; John A Lawson; Sheila H Jacobo; Domenico Pratico'; garret fitzgerald; Kirk Maxey; Joshua Rokach
iPF2alpha-III-17,18,19,20-d4: total synthesis and metabolism.
Bioorganic & medicinal chemistry letters 2005;15(6):1613-7.
2005: Maria B Kadiiska; Beth C Gladen; Donna D Baird; LB Graham; Carol Parker; Bruce N Ames; S Basu; garret fitzgerald; J A Lawson; Lawrence J Marnett; J D Morrow; D M Murray; J Plastaras; L J Roberts; J Rokach; Mark K Shigenaga; J Sun; Patrick B Walter; Kenneth B Tomer; JC Barrett; Ronald P Mason
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.
Free radical biology & medicine 2005;38(6):711-8.
2005: M B Kadiiska; B C Gladen; D D Baird; D Germolec; L B Graham; Carol Parker; A Nyska; J T Wachsman; B N Ames; S Basu; N Brot; garret fitzgerald; R A Floyd; M George; J W Heinecke; G E Hatch; Kenneth Hensley; J A Lawson; Lawrence J Marnett; J D Morrow; D M Murray; J Plastaras; L J Roberts; J Rokach; M K Shigenaga; R S Sohal; J Sun; R R Tice; D H Van Thiel; D Wellner; Patrick B Walter; K B Tomer; R P Mason; J C Barrett
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
Free radical biology & medicine 2005;38(6):698-710.
2005: Barbara Pini; Tilo Grosser; John A Lawson; Thomas S Price; Michael Pack; garret fitzgerald
Prostaglandin E synthases in zebrafish.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(2):315-20.
2005: Karine M Egan; Miao Wang; Susanne Fries; Margaret B Lucitt; Alicia Zukas; Ellen Puré; John A Lawson; garret fitzgerald
Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.
Circulation 2005;111(3):334-42.
2005: Curt D Furberg; Bruce M Psaty; garret fitzgerald
Parecoxib, valdecoxib, and cardiovascular risk.
Circulation 2005;111(3):249.
2005: Radu Daniel Rudic; Anne M Curtis; Yan Cheng; garret fitzgerald
Peripheral clocks and the regulation of cardiovascular and metabolic function.
Methods in enzymology 2005;393():524-39.
2004: Karine M Egan; John A Lawson; Susanne Fries; Beverly H Koller; Daniel J Rader; Emer M Smyth; garret fitzgerald
COX-2-derived prostacyclin confers atheroprotection on female mice.
Science (New York, N.Y.) 2004;306(5703):1954-7.
2004: Yiqun Hui; Yan Cheng; Isabella Smalera; Wenying Jian; Lawrence Goldhahn; garret fitzgerald; Colin D Funk
Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure.
Circulation 2004;110(21):3360-6.
2004: Radu Daniel Rudic; Peter McNamara; Anne M Curtis; Raymond C Boston; Satchidananda Panda; John B Hogenesch; garret fitzgerald
BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis.
PLoS biology 2004;2(11):e377.
2004: garret fitzgerald
Coxibs and cardiovascular disease.
The New England journal of medicine 2004;351(17):1709-11.
2004: Koichi Hashimoto; Barney S Graham; Mark W Geraci; garret fitzgerald; Karine Egan; Weisong Zhou; Kasia Goleniewska; Jamye F O'Neal; Jason D Morrow; Russell K Durbin; Peter F Wright; Robert D Collins; Tatsuo Suzutani; R Stokes Peebles
Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness.
Journal of virology 2004;78(19):10303-9.
2004: Charles H Hennekens; Karsten Schror; Steven Weisman; garret fitzgerald
Terms and conditions: semantic complexity and aspirin resistance.
Circulation 2004;110(12):1706-8.
2004: Carlo Patrono; Barry S Coller; garret fitzgerald; Jack Hirsh; Gerald J Roth
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):234S-264S.
2004: Trey K Sato; Satchidananda Panda; Loren Miraglia; Teresa Reyes; Radu Daniel Rudic; Peter McNamara; Kinnery A Naik; garret fitzgerald; Steve A Kay; John B Hogenesch
A functional genomics strategy reveals Rora as a component of the mammalian circadian clock.
Neuron 2004;43(4):527-37.
2004: garret fitzgerald
Prostaglandins: modulators of inflammation and cardiovascular risk.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2004;10(3 Suppl):S12-7.
2004: Domenico Pratico'; Joshua Rokach; John Lawson; garret fitzgerald
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
Chemistry and physics of lipids 2004;128(1-2):165-71.
2004: Joshua Rokach; Seongjin Kim; Sophie Bellone; John A Lawson; Domenico Pratico'; William S Powell; garret fitzgerald
Total synthesis of isoprostanes: discovery and quantitation in biological systems.
Chemistry and physics of lipids 2004;128(1-2):35-56.
2004: Anne M Curtis; Sang-Beom Seo; Elizabeth J Westgate; Radu Daniel Rudic; Emer M Smyth; Debabrata Chakravarti; garret fitzgerald; Peter McNamara
Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.
The Journal of biological chemistry 2004;279(8):7091-7.
2004: Devashish Kothapalli; Ilia V Fuki; Kamilah Ali; Sheryl A Stewart; Liang Zhao; Ron Yahil; David Kwiatkowski; Elizabeth A Hawthorne; garret fitzgerald; Michael C Phillips; Sissel Lund-Katz; Ellen Puré; Daniel J Rader; Richard K Assoian
Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.
The Journal of clinical investigation 2004;113(4):609-18.
2003: garret fitzgerald
COX-2 and beyond: Approaches to prostaglandin inhibition in human disease.
Nature reviews. Drug discovery 2003;2(11):879-90.
2003: Kathy K Griendling; garret fitzgerald
Oxidative stress and cardiovascular injury: Part II: animal and human studies.
Circulation 2003;108(17):2034-40.
2003: Kathy K Griendling; garret fitzgerald
Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.
Circulation 2003;108(16):1912-6.
2003: L Chastine Bell-Parikh; Tomomi Ide; John A Lawson; Peter McNamara; Muredach Reilly; garret fitzgerald
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.
The Journal of clinical investigation 2003;112(6):945-55.
2003: Anne Burke; garret fitzgerald
Oxidative stress and smoking-induced vascular injury.
Progress in cardiovascular diseases 2003;46(1):79-90.
2003: Tomomi Ide; Karine Egan; L Chastine Bell-Parikh; garret fitzgerald
Activation of nuclear receptors by prostaglandins.
Thrombosis research 2003;110(5-6):311-5.
2003: Zhibing Zhang; Roberta Vezza; Theodore Plappert; Peter McNamara; John A Lawson; Sandra Austin; Domenico Pratico'; Martin St John Sutton; garret fitzgerald
COX-2-dependent cardiac failure in Gh/tTG transgenic mice.
Circulation research 2003;92(10):1153-61.
2003: Domenico Ferro; Michele Saliola; P L Meroni; Guido Valesini; C Caroselli; Domenico Pratico'; garret fitzgerald; Y Shoenfeld; Francesco Violi
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment.
Journal of thrombosis and haemostasis : JTH 2003;1(3):523-31.
2003: garret fitzgerald
Parsing an enigma: the pharmacodynamics of aspirin resistance.
Lancet 2003;361(9357):542-4.
2002: Anne Burke; garret fitzgerald; Michael R Lucey
A prospective analysis of oxidative stress and liver transplantation.
Transplantation 2002;74(2):217-21.
2002: Lee S Simon; Josef S Smolen; Steven B Abramson; Gerald Appel; Claire Bombardier; D Craig Brater; Ferdinand C Breedveld; K Brune; Gerd R Burmester; Leslie J Crofford; Maxime Dougados; Raymond DuBois; garret fitzgerald; W Frishman; Luis A García Rodríguez; Marc C Hochberg; Joachim R Kalden; Loren Laine; M J S Langman; Stephen M Prescott; L B A Van De Putte; Andrew Whelton; William B White; Gordon H Willaims
Controversies in COX-2 selective inhibition.
The Journal of rheumatology 2002;29(7):1501-10.
2002: garret fitzgerald
The choreography of cyclooxygenases in the kidney.
The Journal of clinical investigation 2002;110(1):33-4.
2002: Tilo Grosser; Shamila Yusuff; Ellina Cheskis; Michael Pack; garret fitzgerald
Developmental expression of functional cyclooxygenases in zebrafish.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(12):8418-23.
2002: Yan Cheng; Sandra C Austin; Bianca Rocca; Beverly H Koller; Thomas M Coffman; Tilo Grosser; John A Lawson; garret fitzgerald
Role of prostacyclin in the cardiovascular response to thromboxane A2.
Science (New York, N.Y.) 2002;296(5567):539-41.
2002: Bianca Rocca; garret fitzgerald
Cyclooxygenases and prostaglandins: shaping up the immune response.
International immunopharmacology 2002;2(5):603-30.
2002: garret fitzgerald
Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations.
The American journal of cardiology 2002;89(6A):26D-32D.
2002: garret fitzgerald
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach.
The American journal of cardiology 2002;89(6A):1D-2D.
2002: Muredach Reilly; garret fitzgerald
Gathering intelligence on antiplatelet drugs: the view from 30 000 feet. When combined with other information overviews lead to conviction.
BMJ (Clinical research ed.) 2002;324(7329):59-60.
2002: Peter McNamara; John A Lawson; Joshua Rokach; garret fitzgerald
Isoprostane activation of the nuclear hormone receptor PPAR.
Advances in experimental medicine and biology 2002;507():351-5.
2002: Emer M Smyth; Sandra C Austin; garret fitzgerald
Activation-dependent internalization of the human prostacyclin receptor.
Advances in experimental medicine and biology 2002;507():295-301.
2002: Emer M Smyth; garret fitzgerald
Human prostacyclin receptor.
Vitamins and hormones 2002;65():149-65.
2001: F Catella-Lawson; Muredach P Reilly; SC Kapoor; Andrew J Cucchiara; S DeMarco; B Tournier; S N Vyas; garret fitzgerald
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
The New England journal of medicine 2001;345(25):1809-17.
2001: C Patrono; garret fitzgerald
Oxidant stress in cardiovascular disease: an emerging modality or a disproved theory?
Italian heart journal : official journal of the Italian Federation of Cardiology 2001;2(12):865-6.
2001: garret fitzgerald
Bioactive lipids and atherothrombosis.
Haematologica 2001;86(11 Suppl 2):3-7.
2001: garret fitzgerald; Yan Cheng; S Austin
COX-2 inhibitors and the cardiovascular system.
Clinical and experimental rheumatology 2001;19(6 Suppl 25):S31-6.
2001: Tillmann Cyrus; Lina X Tang; Joshua Rokach; garret fitzgerald; Domenico Pratico'
Lipid peroxidation and platelet activation in murine atherosclerosis.
Circulation 2001;104(16):1940-5.
2001: P McNamara; garret fitzgerald
Smoking-induced vascular disease: a new twist on an old theme.
Circulation research 2001;89(7):563-5.
2001: Yousef Al-Abed; S Vanpatten; H Li; J A Lawson; garret fitzgerald; K R Manogue; Richard Bucala
Characterization of a novel hemoglobin-glutathione adduct that is elevated in diabetic patients.
Molecular medicine (Cambridge, Mass.) 2001;7(9):619-23.
2001: C L Regan; Richard J Levine; D D Baird; Marian G Ewell; K L Martz; Baha M Sibai; Joshua Rokach; John A Lawson; garret fitzgerald
No evidence for lipid peroxidation in severe preeclampsia.
American journal of obstetrics and gynecology 2001;185(3):572-8.
2001: garret fitzgerald; Carlo Patrono
The coxibs, selective inhibitors of cyclooxygenase-2.
The New England journal of medicine 2001;345(6):433-42.
2001: F Catella-Lawson; Shiv Kapoor; D Moretti; S De Marco; G J Vigilante; Andrew J Cucchiara; K E Ramsey; S Combe; Bianca Rocca; P Theroux; garret fitzgerald
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease.
The American journal of cardiology 2001;88(3):236-42.
2001: Domenico Pratico'; John A Lawson; Joshua Rokach; garret fitzgerald
The isoprostanes in biology and medicine.
Trends in endocrinology and metabolism: TEM 2001;12(6):243-7.
2001: Shuh Narumiya; garret fitzgerald
Genetic and pharmacological analysis of prostanoid receptor function.
The Journal of clinical investigation 2001;108(1):25-30.
2001: Peter McNamara; S B Seo; Radu Daniel Rudic; Amita Sehgal; Debabrata Chakravarti; garret fitzgerald
Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock.
Cell 2001;105(7):877-89.
2001: garret fitzgerald; Patrick J Loll
COX in a crystal ball: current status and future promise of prostaglandin research.
The Journal of clinical investigation 2001;107(11):1335-7.
2001: Roberta Vezza; Joshua Rokach; garret fitzgerald
Prostaglandin F(2alpha) receptor-dependent regulation of prostaglandin transport.
Molecular pharmacology 2001;59(6):1506-13.
2001: Joel S Bennett; F Catella-Lawson; A R Rut; Gaston Vilaire; W Qi; SC Kapoor; S Murphy; garret fitzgerald
Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
Blood 2001;97(10):3093-9.
2001: Tillmann Cyrus; Domenico Pratico'; Lei Zhao; Joseph L Witztum; Daniel J Rader; Joshua Rokach; garret fitzgerald; Colin D Funk
Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.
Circulation 2001;103(18):2277-82.
2001: Issam A Mardini; garret fitzgerald
Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs.
Molecular interventions 2001;1(1):30-8.
2001: garret fitzgerald; J L Witztum
Oxidative stress. Introduction.
Trends in cardiovascular medicine 2001;11(3-4):91-2.
2001: Domenico Pratico'; C Tillmann; Z B Zhang; Hui Li; garret fitzgerald
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(6):3358-63.
2001: emma meagher; OP Barry; John A Lawson; Joshua Rokach; garret fitzgerald
Effects of vitamin E on lipid peroxidation in healthy persons.
JAMA : the journal of the American Medical Association 2001;285(9):1178-82.
2001: Jean-Etienne Fabre; MyTrang Nguyen; Krairerk Athirakul; Kenneth G Coggins; John McNeish; S Austin; L K Parise; garret fitzgerald; Thomas M Coffman; Beverly H Koller
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation.
The Journal of clinical investigation 2001;107(5):603-10.
2001: Domenico Pratico'; Rajendra K Tangirala; Sohvi Hörkkö; Joseph L Witztum; Wulf Palinski; garret fitzgerald
Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E.
Blood 2001;97(2):459-64.
2001: Rajendra K Tangirala; D Praticó; garret fitzgerald; S Chun; K Tsukamoto; Cyrille Maugeais; David Usher; Ellen Puré; Daniel J Rader
Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E.
The Journal of biological chemistry 2001;276(1):261-6.
2001: A S Whitehead; garret fitzgerald
Twenty-first century phox: not yet ready for widespread screening.
Circulation 2001;103(1):7-9.
2001: C Patrono; Barry S Coller; J E Dalen; garret fitzgerald; V Fuster; M Gent; J Hirsh; Gerald J Roth
Platelet-active drugs : the relationships among dose, effectiveness, and side effects.
Chest 2001;119(1 Suppl):39S-63S.
2001: Luigi Iuliano; Domenico Pratico'; Cesare Greco; Enrico Mangieri; G Scibilia; garret fitzgerald; Francesco Violi
Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA.
Journal of the American College of Cardiology 2001;37(1):76-80.
2000: garret fitzgerald; Sandra Austin; Karine Egan; Yan Cheng; Domenico Pratico'
Cyclo-oxygenase products and atherothrombosis.
Annals of medicine 2000;32 Suppl 1():21-6.
2000: Domenico Pratico'; Tillmann Cyrus; Hui Li; garret fitzgerald
Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis.
Blood 2000;96(12):3823-6.
2000: Domenico Pratico'; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski; Joshua Rokach; garret fitzgerald
Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
Annals of neurology 2000;48(5):809-12.
2000: Emer M Smyth; Sandra C Austin; M P Reilly; garret fitzgerald
Internalization and sequestration of the human prostacyclin receptor.
The Journal of biological chemistry 2000;275(41):32037-45.
2000: Edward A Weinstein; Hui Li; John A Lawson; Joshua Rokach; garret fitzgerald; Paul H Axelsen
Prothrombinase acceleration by oxidatively damaged phospholipids.
The Journal of biological chemistry 2000;275(30):22925-30.
2000: D Praticó; Y Cheng; garret fitzgerald
TP or not TP: primary mediators in a close runoff?
Arteriosclerosis, thrombosis, and vascular biology 2000;20(7):1695-8.
2000: Laurent P Audoly; Bianca Rocca; Jean-Etienne Fabre; Beverly H Koller; D Thomas; AL Loeb; Thomas M Coffman; garret fitzgerald
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo.
Circulation 2000;101(24):2833-40.
2000: emma meagher; garret fitzgerald
Indices of lipid peroxidation in vivo: strengths and limitations.
Free radical biology & medicine 2000;28(12):1745-50.
2000: BF McAdam; Issam A Mardini; Aida Habib; Anne Burke; John A Lawson; Shiv Kapoor; garret fitzgerald
Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation.
The Journal of clinical investigation 2000;105(10):1473-82.
2000: Melpo Christofidou-Solomidou; Giuseppe G Pietra; Charalambos C Solomides; E Arguiris; David Winslow Harshaw; garret fitzgerald; Steven M Albelda; Vladimir R Muzykantov
Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs.
American journal of physiology. Lung cellular and molecular physiology 2000;278(4):L794-805.
2000: Bianca Rocca; AL Loeb; Jerome F Strauss; Roberta Vezza; Aida Habib; Hui Li; garret fitzgerald
Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation.
Nature medicine 2000;6(2):219-21.
2000: Anne Burke; John A Lawson; emma meagher; Joshua Rokach; garret fitzgerald
Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid.
The Journal of biological chemistry 2000;275(4):2499-504.
1999: Hui Li; John A Lawson; M Reilly; M Adiyaman; SW Hwang; Joshua Rokach; garret fitzgerald
Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(23):13381-6.
1999: emma meagher; OP Barry; Anne Burke; Michael R Lucey; John A Lawson; Joshua Rokach; garret fitzgerald
Alcohol-induced generation of lipid peroxidation products in humans.
The Journal of clinical investigation 1999;104(6):805-13.
1999: John A Lawson; Joshua Rokach; garret fitzgerald
Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo.
The Journal of biological chemistry 1999;274(35):24441-4.
1999: OP Barry; garret fitzgerald
Mechanisms of cellular activation by platelet microparticles.
Thrombosis and haemostasis 1999;82(2):794-800.
1999: D Praticó; M Pasin; OP Barry; Andrea Ghiselli; G Sabatino; Luigi Iuliano; garret fitzgerald; Francesco Violi
Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C.
Circulation 1999;99(24):3118-24.
1999: S Austin; garret fitzgerald
Not a mouse stirring: deletion of the EP2 and love's labor's lost.
The Journal of clinical investigation 1999;103(11):1481-2.
1999: Bianca Rocca; Lisa M. Spain; Ellen Puré; R Langenbach; Carlo Patrono; garret fitzgerald
Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development.
The Journal of clinical investigation 1999;103(10):1469-77.
1999: Domenico Pratico'; Domenico Ferro; Luigi Iuliano; Joshua Rokach; F Conti; Guido Valesini; garret fitzgerald; Francesco Violi
Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation.
Blood 1999;93(10):3401-7.
1999: Domenico Ferro; Stefania Basili; D Praticó; Luigi Iuliano; garret fitzgerald; F Violi
Vitamin E reduces monocyte tissue factor expression in cirrhotic patients.
Blood 1999;93(9):2945-50.
1999: F Catella-Lawson; BF McAdam; B W Morrison; Shiv Kapoor; D Kujubu; L Antes; K C Lasseter; H Quan; Barry J Gertz; garret fitzgerald
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
The Journal of pharmacology and experimental therapeutics 1999;289(2):735-41.
1999: Roberta Vezza; Aida Habib; garret fitzgerald
Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh.
The Journal of biological chemistry 1999;274(18):12774-9.
1999: Bianca Rocca; Lisa M. Spain; Giovanni Ciabattoni; Carlo Patrono; garret fitzgerald
Differential expression and regulation of cyclooxygenase isozymes in thymic stromal cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4589-97.
1999: OP Barry; Marcelo G Kazanietz; Domenico Pratico'; garret fitzgerald
Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway.
The Journal of biological chemistry 1999;274(11):7545-56.
1999: Yousef Al-Abed; T Mitsuhashi; H Li; J A Lawson; garret fitzgerald; HW Founds; T Donnelly; Anthony Cerami; PC Ulrich; Richard Bucala
Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(5):2385-90.
1999: Aida Habib; garret fitzgerald; Jacques Maclouf
Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.
The Journal of biological chemistry 1999;274(5):2645-51.
1999: BF McAdam; F Catella-Lawson; Issam A Mardini; Shiv Kapoor; John A Lawson; garret fitzgerald
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(1):272-7.
1998: Muredach P Reilly; Domenico Pratico'; N Delanty; G DiMinno; E Tremoli; Daniel J Rader; S Kapoor; Joshua Rokach; J Lawson; garret fitzgerald
Increased formation of distinct F2 isoprostanes in hypercholesterolemia.
Circulation 1998;98(25):2822-8.
1998: Domenico Pratico'; E Rossi; M Merli; O Riggio; garret fitzgerald; Francesco Violi
Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1998;46(9):430-4.
1998: Domenico Pratico'; Stefania Basili; M Vieri; C Cordova; Francesco Violi; garret fitzgerald
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
American journal of respiratory and critical care medicine 1998;158(6):1709-14.
1998: Domenico Pratico'; V MY Lee; John Q Trojanowski; Joshua Rokach; garret fitzgerald
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1998;12(15):1777-83.
1998: John A Lawson; Hui Li; Joshua Rokach; M Adiyaman; SW Hwang; SP Khanapure; garret fitzgerald
Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.
The Journal of biological chemistry 1998;273(45):29295-301.
1998: R A Baughman; SC Kapoor; R K Agarwal; J Kisicki; F Catella-Lawson; garret fitzgerald
Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans.
Circulation 1998;98(16):1610-5.
1998: Domenico Pratico'; Rajendra K Tangirala; Daniel J Rader; Joshua Rokach; garret fitzgerald
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice.
Nature medicine 1998;4(10):1189-92.
1998: Emer M Smyth; W H Li; garret fitzgerald
Phosphorylation of the prostacyclin receptor during homologous desensitization. A critical role for protein kinase c.
The Journal of biological chemistry 1998;273(36):23258-66.
1998: P Kunapuli; John A Lawson; Joshua Rokach; Judy L Meinkoth; garret fitzgerald
Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways.
The Journal of biological chemistry 1998;273(35):22442-52.
1998: M Adiyaman; John A Lawson; SP Khanapure; garret fitzgerald; Joshua Rokach
Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry.
Analytical biochemistry 1998;262(1):45-56.
1998: D J Rader; garret fitzgerald
State of the art: atherosclerosis in a limited edition.
Nature medicine 1998;4(8):899-900.
1998: C L Regan; B F McAdam; P McParland; P C Boylan; garret fitzgerald; Desmond J Fitzgerald
Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies.
British journal of obstetrics and gynaecology 1998;105(7):732-8.
1998: OP Barry; Domenico Pratico'; Rashmin C Savani; garret fitzgerald
Modulation of monocyte-endothelial cell interactions by platelet microparticles.
The Journal of clinical investigation 1998;102(1):136-44.
1998: Jennifer S Read; Carl E Frasch; Kenneth C Rich; garret fitzgerald; John D Clemens; Jane Pitt; Stephen I Pelton; I C Hanson; Edward Handelsman; Clemente Diaz; Mary Glenn Fowler
The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group.
The Pediatric infectious disease journal 1998;17(5):391-7.
1998: garret fitzgerald; W N Charman
Interpretation of Thrombosis Prevention Trial.
Lancet 1998;351(9110):1206-7.
1998: Domenico Pratico'; OP Barry; John A Lawson; M Adiyaman; SW Hwang; SP Khanapure; Luigi Iuliano; Joshua Rokach; garret fitzgerald
IPF2alpha-I: an index of lipid peroxidation in humans.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3449-54.
1998: Domenico Pratico'; Luigi Iuliano; Stefania Basili; Domenico Ferro; C Camastra; C Cordova; garret fitzgerald; Francesco Violi
Enhanced lipid peroxidation in hepatic cirrhosis.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1998;46(2):51-7.
1998: Muredach P Reilly; John A Lawson; garret fitzgerald
Eicosanoids and isoeicosanoids: indices of cellular function and oxidant stress.
The Journal of nutrition 1998;128(2 Suppl):434S-438S.
1998: L T Seery; P V Nestor; garret fitzgerald
Molecular evolution of the aldo-keto reductase gene superfamily.
Journal of molecular evolution 1998;46(2):139-46.
1997: Joshua Rokach; SP Khanapure; S W Hwang; M Adiyaman; John A Lawson; garret fitzgerald
Nomenclature of isoprostanes: a proposal.
Prostaglandins 1997;54(6):853-73.
1997: Joshua Rokach; SP Khanapure; S W Hwang; M Adiyaman; John A Lawson; garret fitzgerald
The isoprostanes: a perspective.
Prostaglandins 1997;54(6):823-51.
1997: Muredach P Reilly; N Delanty; L Roy; Joshua Rokach; P O Callaghan; P Crean; John A Lawson; garret fitzgerald
Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans.
Circulation 1997;96(10):3314-20.
1997: Luigi Iuliano; Domenico Pratico'; Domenico Ferro; Valerio Pittoni; Guido Valesini; J Lawson; garret fitzgerald; Francesco Violi
Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies.
Blood 1997;90(10):3931-5.
1997: Carlo Patrono; garret fitzgerald
Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(11):2309-15.
1997: P Kunapuli; John A Lawson; Joshua Rokach; garret fitzgerald
Functional characterization of the ocular prostaglandin f2alpha (PGF2alpha) receptor. Activation by the isoprostane, 12-iso-PGF2alpha.
The Journal of biological chemistry 1997;272(43):27147-54.
1997: Domenico Pratico'; Luigi Iuliano; Alessandro Mauriello; Luigi Giusto Spagnoli; John A Lawson; Joshua Rokach; Jacques Maclouf; Francesco Violi; garret fitzgerald
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
The Journal of clinical investigation 1997;100(8):2028-34.
1997: garret fitzgerald; J Tigges; P Barry; J A Lawson
Markers of platelet activation and oxidant stress in atherothrombotic disease.
Thrombosis and haemostasis 1997;78(1):280-4.
1997: N Delanty; Muredach P Reilly; Domenico Pratico'; John A Lawson; J F McCarthy; Alfred E Wood; S T Ohnishi; Desmond J Fitzgerald; garret fitzgerald
8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.
Circulation 1997;95(11):2492-9.
1997: garret fitzgerald
Cigarettes and the wages of sn-2: oxidized species of PAF in smoking hamsters.
The Journal of clinical investigation 1997;99(10):2300-1.
1997: B Therese Kinsella; D J O'Mahony; garret fitzgerald
The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
The Journal of pharmacology and experimental therapeutics 1997;281(2):957-64.
1997: OP Barry; Domenico Pratico'; John A Lawson; garret fitzgerald
Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.
The Journal of clinical investigation 1997;99(9):2118-27.
1997: garret fitzgerald; P Barry
Dietary factors in thrombosis and hemostasis: summary and conclusions.
The American journal of clinical nutrition 1997;65(5 Suppl):1699S-1701S.
1997: Aida Habib; Roberta Vezza; C Créminon; Jacques Maclouf; garret fitzgerald
Rapid, agonist-dependent phosphorylation in vivo of human thromboxane receptor isoforms. Minimal involvement of protein kinase C.
The Journal of biological chemistry 1997;272(11):7191-200.
1997: R Leo; Domenico Pratico'; Luigi Iuliano; Fabio M Pulcinelli; Andrea Ghiselli; Pasquale Pignatelli; A R Colavita; garret fitzgerald; Francesco Violi
Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated.
Circulation 1997;95(4):885-91.
1997: F Catella-Lawson; garret fitzgerald
Confusion in reperfusion. Problems in the clinical development of antithrombotic drugs.
Circulation 1997;95(4):793-5.
1997: B Rocca; garret fitzgerald
Simply read: erythrocytes modulate platelet function. Should we rethink the way we give aspirin?
Circulation 1997;95(1):11-3.
1997: Domenico Pratico'; D O'Mahony; J Lawson; T Kinsella; garret fitzgerald
Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha.
Advances in experimental medicine and biology 1997;400A():229-33.
1997: Domenico Pratico'; M Reilly; John A Lawson; garret fitzgerald
Novel indices of oxidant stress in cardiovascular disease: specific analysis of F2-isoprostanes.
Agents and actions. Supplements 1997;48():25-41.
1996: Emer M Smyth; P V Nestor; garret fitzgerald
Agonist-dependent phosphorylation of an epitope-tagged human prostacyclin receptor.
The Journal of biological chemistry 1996;271(52):33698-704.
1996: garret fitzgerald
The human pharmacology of thrombin inhibition.
Coronary artery disease 1996;7(12):911-8.
1996: Roberta Vezza; Aida Habib; Hui Li; John A Lawson; garret fitzgerald
Regulation of cyclooxygenases by protein kinase C. Evidence against the importance of direct enzyme phosphorylation.
The Journal of biological chemistry 1996;271(47):30028-33.
1996: M Reilly; Norman Delanty; John A Lawson; garret fitzgerald
Modulation of oxidant stress in vivo in chronic cigarette smokers.
Circulation 1996;94(1):19-25.
1996: Norman Delanty; M Reilly; Domenico Pratico'; D J FitzGerald; John A Lawson; garret fitzgerald
8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo.
British journal of clinical pharmacology 1996;42(1):15-9.
1996: Domenico Pratico'; Emer M Smyth; Francesco Violi; garret fitzgerald
Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms.
The Journal of biological chemistry 1996;271(25):14916-24.
1996: D Praticó; garret fitzgerald
Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2.
The Journal of biological chemistry 1996;271(15):8919-24.
1996: F Catella-Lawson; garret fitzgerald
Oxidative stress and platelet activation in diabetes mellitus.
Diabetes research and clinical practice 1996;30 Suppl():13-8.
1995: Z Wang; G Ciabattoni; C Créminon; J Lawson; garret fitzgerald; C Patrono; Jacques Maclouf
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
The Journal of pharmacology and experimental therapeutics 1995;275(1):94-100.
1995: F Catella-Lawson; garret fitzgerald
Long-term aspirin in the prevention of cardiovascular disorders. Recent developments and variations on a theme.
Drug safety : an international journal of medical toxicology and drug experience 1995;13(2):69-75.
1995: Domenico Pratico'; garret fitzgerald
Testosterone and thromboxane. Of muscles, mice, and men.
Circulation 1995;91(11):2694-8.
1995: Domenico Pratico'; John A Lawson; garret fitzgerald
Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha.
The Journal of biological chemistry 1995;270(17):9800-8.
1995: B Therese Kinsella; D J O'Mahony; F Griffin; garret fitzgerald
Regulated expression of the gene coding for the human thromboxane A2 receptor.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():247-9.
1995: F Catella; Muredach P Reilly; Norman Delanty; John A Lawson; N Moran; emma meagher; garret fitzgerald
Physiological formation of 8-epi-PGF2 alpha in vivo is not affected by cyclooxygenase inhibition.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():233-6.
1995: Domenico Pratico'; John A Lawson; garret fitzgerald
Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets.
Advances in prostaglandin, thromboxane, and leukotriene research 1995;23():229-31.
1995: Domenico Pratico'; M Reilly; J Lawson; Norman Delanty; garret fitzgerald
Formation of 8-iso-prostaglandin F2 alpha by human platelets.
Agents and actions. Supplements 1995;45():27-31.
1994: B Therese Kinsella; D J O'Mahony; garret fitzgerald
Phosphorylation and regulated expression of the human thromboxane A2 receptor.
The Journal of biological chemistry 1994;269(47):29914-9.
1994: Domenico Pratico'; John A Lawson; garret fitzgerald
Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha.
Annals of the New York Academy of Sciences 1994;744():139-45.
1994: Monique Ernst; L L Liebenauer; A C King; garret fitzgerald; Robert M Cohen; Alan J Zametkin
Reduced brain metabolism in hyperactive girls.
Journal of the American Academy of Child and Adolescent Psychiatry 1994;33(6):858-68.
1994: A Nordøy; L Hatcher; S Goodnight; garret fitzgerald; W E Conner
Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men.
The Journal of laboratory and clinical medicine 1994;123(6):914-20.
1994: B Therese Kinsella; D O'Mahony; John A Lawson; Domenico Pratico'; garret fitzgerald
Cellular activation of thromboxane receptors.
Annals of the New York Academy of Sciences 1994;714():270-8.
1994: Ryszard Dworski; garret fitzgerald; J A Oates; James R Sheller
Effect of oral prednisone on airway inflammatory mediators in atopic asthma.
American journal of respiratory and critical care medicine 1994;149(4 Pt 1):953-9.
1994: garret fitzgerald; emma meagher
Antiplatelet drugs.
European journal of clinical investigation 1994;24 Suppl 1():46-9.
1994: Monique Ernst; Alan J Zametkin; John A Matochik; L Liebenauer; garret fitzgerald; Robert M Cohen
Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings.
Psychopharmacology bulletin 1994;30(2):219-25.
1994: Robert C Murphy; garret fitzgerald
Current approaches to estimation of eicosanoid formation in vivo.
Advances in prostaglandin, thromboxane, and leukotriene research 1994;22():341-8.
1993: Colin D Funk; L Furci; garret fitzgerald; R Grygorczyk; C Rochette; M A Bayne; Mark Abramovitz; M Adam; Kathleen M Metters
Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype.
The Journal of biological chemistry 1993;268(35):26767-72.
1993: M Reilly; garret fitzgerald
Cellular activation by thromboxane A2 and other eicosanoids.
European heart journal 1993;14 Suppl K():88-93.
1993: W N Charman; S A Charman; D C Monkhouse; S E Frisbee; E A Lockhart; S Weisman; garret fitzgerald
Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.
British journal of clinical pharmacology 1993;36(5):470-3.
1993: Colin D Funk; L Furci; N Moran; garret fitzgerald
Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites.
Molecular pharmacology 1993;44(5):934-9.
1993: N L Benowitz; garret fitzgerald; M Wilson; Q Zhang
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking.
Journal of the American College of Cardiology 1993;22(4):1159-67.
1993: emma meagher; garret fitzgerald
Disordered eicosanoid formation in pregnancy-induced hypertension.
Circulation 1993;88(3):1324-33.
1993: Alan J Zametkin; L L Liebenauer; garret fitzgerald; A C King; D V Minkunas; Peter Herscovitch; E M Yamada; Robert M Cohen
Brain metabolism in teenagers with attention-deficit hyperactivity disorder.
Archives of general psychiatry 1993;50(5):333-40.
1993: J D Sørensen; Sjurdur F Olsen; A K Pedersen; J Boris; Niels Jørgen Secher; garret fitzgerald
Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production.
American journal of obstetrics and gynecology 1993;168(3 Pt 1):915-22.
1993: LA Harker; Andrew B Kelly; Stephen R Hanson; W Krupski; A Bass; B Osterud; garret fitzgerald; S H Goodnight; William E Connor
Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates.
Circulation 1993;87(3):1017-29.
1992: S H Goodnight; J A Cairns; M Fisher; garret fitzgerald
Assessment of the therapeutic use of n-3 fatty acids in vascular disease and thrombosis.
Chest 1992;102(4 Suppl):374S-384S.
1992: garret fitzgerald; E Shipp
Antiplatelet and anticoagulant drugs in coronary vascular disease.
Annals of epidemiology 1992;2(4):529-42.
1992: G Remuzzi; garret fitzgerald; C Patrono
Thromboxane synthesis and action within the kidney.
Kidney international 1992;41(6):1483-93.
1992: Colin D Funk; L B Funk; garret fitzgerald; Bengt Samuelsson
Characterization of human 12-lipoxygenase genes.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(9):3962-6.
1992: S Kunitada; garret fitzgerald; D J Fitzgerald
Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
Blood 1992;79(6):1420-7.
1992: DM Kerins; L Roy; S Kunitada; Adedayo Adedoyin; garret fitzgerald; D J Fitzgerald
Pharmacokinetics of tissue-type plasminogen activator during acute myocardial infarction in men. Effect of a prostacyclin analogue.
Circulation 1992;85(2):526-32.
1992: Ryszard Dworski; garret fitzgerald; James R Sheller
Thromboxane synthase inhibition in allergen challenged sheep lung: effect on eicosanoid synthesis.
Eicosanoids 1992;5(1):35-7.
1992: H R Knapp; Krzysztof Sladek; garret fitzgerald
Increased excretion of leukotriene E4 during aspirin-induced asthma.
The Journal of laboratory and clinical medicine 1992;119(1):48-51.
1991: garret fitzgerald; M Lupinetti; S A Charman; W N Charman
Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2.
The Journal of pharmacology and experimental therapeutics 1991;259(3):1043-9.
1991: D J Fitzgerald; M Hanson; garret fitzgerald
Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.
The Journal of clinical investigation 1991;88(5):1589-95.
1991: R J Clarke; G Mayo; P Price; garret fitzgerald
Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
The New England journal of medicine 1991;325(16):1137-41.
1991: garret fitzgerald
Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists.
The American journal of cardiology 1991;68(7):11B-15B.
1991: G A Braden; H R Knapp; garret fitzgerald
Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin.
Circulation 1991;84(2):679-85.
1991: Colin D Funk; garret fitzgerald
Eicosanoid forming enzyme mRNA in human tissues. Analysis by quantitative polymerase chain reaction.
The Journal of biological chemistry 1991;266(19):12508-13.
1991: L Furci; D J Fitzgerald; garret fitzgerald
Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
The Journal of pharmacology and experimental therapeutics 1991;258(1):74-81.
1991: Colin D Funk; L B Funk; M E Kennedy; A S Pong; garret fitzgerald
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1991;5(9):2304-12.
1991: R J Clarke; G Mayo; garret fitzgerald; D J Fitzgerald
Combined administration of aspirin and a specific thrombin inhibitor in man.
Circulation 1991;83(5):1510-8.
1991: DM Kerins; garret fitzgerald
The current role of platelet-active drugs in ischaemic heart disease.
Drugs 1991;41(5):665-71.
1991: DM Kerins; M Shuh; S Kunitada; garret fitzgerald; D J Fitzgerald
A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction.
The Journal of pharmacology and experimental therapeutics 1991;257(1):487-92.
1991: D J Fitzgerald; garret fitzgerald
Antiplatelet and anticoagulant therapy during coronary thrombolysis.
Trends in cardiovascular medicine 1991;1(1):29-35.
1991: D M Kerins; R Murray; garret fitzgerald
Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.
Progress in hemostasis and thrombosis 1991;10():307-37.
1991: Krzysztof Sladek; James R Sheller; garret fitzgerald; Jason D Morrow; L Jackson Roberts
Formation of PGD2 after allergen inhalation in atopic asthmatics.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():433-6.
1991: Colin D Funk; L Furci; garret fitzgerald
Polymerase chain reaction cloning and expression of eicosanoid metabolizing enzymes from blood cells.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():33-6.
1991: garret fitzgerald; R Murray; N Moran; C Funk; W Charman; R Clarke; L Furci; D J Fitzgerald
Mechanisms of eicosanoid action.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21B():577-81.
1991: Robert B Cotton; J L Haywood; garret fitzgerald
Symptomatic patent ductus arteriosus following prophylactic indomethacin. A clinical and biochemical appraisal.
Biology of the neonate 1991;60(5):273-82.
1991: F Catella; J Lawson; G Braden; D J Fitzgerald; E Shipp; garret fitzgerald
Biosynthesis of P450 products of arachidonic acid in humans: increased formation in cardiovascular disease.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21A():193-6.
1990: R Murray; E Shipp; garret fitzgerald
Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets.
The Journal of biological chemistry 1990;265(35):21670-5.
1990: F Lellouche; A Fradin; garret fitzgerald; Jacques Maclouf
Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin.
Prostaglandins 1990;40(3):297-310.
1990: R J Sebaldt; James R Sheller; John A Oates; L Jackson Roberts; garret fitzgerald
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(18):6974-8.
1990: Colin D Funk; L Furci; garret fitzgerald
Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5638-42.
1990: F Catella; John A Lawson; D J Fitzgerald; garret fitzgerald
Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5893-7.
1990: garret fitzgerald
Ticlopidine in unstable angina. A more expensive aspirin?
Circulation 1990;82(1):296-8.
1990: G A Braden; H R Knapp; D J Fitzgerald; garret fitzgerald
Dietary fish oil accelerates the response to coronary thrombolysis with tissue-type plasminogen activator. Evidence for a modest platelet inhibitory effect in vivo.
Circulation 1990;82(1):178-87.
1990: Krzysztof Sladek; Ryszard Dworski; garret fitzgerald; K L Buitkus; F J Block; S R Marney; James R Sheller
Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin.
The American review of respiratory disease 1990;141(6):1441-5.
1990: Kazuhiko Takahara; R Murray; garret fitzgerald; D J Fitzgerald
The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
The Journal of biological chemistry 1990;265(12):6836-44.
1990: D J Fitzgerald; W Rocki; R Murray; G Mayo; garret fitzgerald
Thromboxane A2 synthesis in pregnancy-induced hypertension.
Lancet 1990;335(8692):751-4.
1990: John Joseph Murray; J Nowak; J A Oates; garret fitzgerald
Platelet-vessel wall interactions in individuals who smoke cigarettes.
Advances in experimental medicine and biology 1990;273():189-98.
1990: F Catella; garret fitzgerald
Measurement of thromboxane metabolites by gas chromatography-mass spectrometry.
Methods in enzymology 1990;187():42-50.
1990: Colin D Funk; L Furci; garret fitzgerald
Molecular cloning of the human platelet 12-lipoxygenase.
Transactions of the Association of American Physicians 1990;103():180-6.
1989: DM Kerins; L Roy; garret fitzgerald; D J Fitzgerald
Platelet and vascular function during coronary thrombolysis with tissue-type plasminogen activator.
Circulation 1989;80(6):1718-25.
1989: M D Lupinetti; James R Sheller; F Catella; garret fitzgerald
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation.
The American review of respiratory disease 1989;140(4):932-5.
1989: D J Fitzgerald; garret fitzgerald
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(19):7585-9.
1989: R Murray; L Furci; garret fitzgerald
Induction of prostacyclin receptor expression in human erythroleukemia cells.
FEBS letters 1989;255(1):172-4.
1989: Ariela Benigni; Chiara Chiabrando; Norberto Perico; Roberto Fanelli; Carlo Patrono; garret fitzgerald; Giuseppe Remuzzi
Renal metabolism and urinary excretion of thromboxane B2 in the rat.
The American journal of physiology 1989;257(1 Pt 2):F77-85.
1989: D J Fitzgerald; F Wright; garret fitzgerald
Increased thromboxane biosynthesis during coronary thrombolysis. Evidence that platelet activation and thromboxane A2 modulate the response to tissue-type plasminogen activator in vivo.
Circulation research 1989;65(1):83-94.
1989: H R Knapp; garret fitzgerald
The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension.
The New England journal of medicine 1989;320(16):1037-43.
1989: S H Goodnight; M Fisher; garret fitzgerald; P H Levine
Assessment of the therapeutic use of dietary fish oil in atherosclerotic vascular disease and thrombosis.
Chest 1989;95(2 Suppl):19S-25S.
1989: J Nowak; garret fitzgerald
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
The Journal of clinical investigation 1989;83(2):380-5.
1989: garret fitzgerald; G Mayo; P Price; Kazuhiko Takahara
Aspirin in cardiovascular disease; biochemical pharmacology and clinical trials.
Progress in clinical and biological research 1989;301():97-106.
1989: garret fitzgerald; G Braden; D J Fitzgerald; H R Knapp
Fish oils in cardiovascular disease.
Journal of internal medicine. Supplement 1989;731():25-9.
1989: R Murray; garret fitzgerald
Regulation of thromboxane receptor activation in human platelets.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(1):124-8.
1989: garret fitzgerald; R Murray; P Price; F Catella
The molecular, biochemical and human pharmacology of thromboxane A2 in renal disease.
Advances in experimental medicine and biology 1989;259():325-60.
1989: Ryszard Dworski; James R Sheller; N E Wickersham; John A Oates; Kenneth L Brigham; L Jackson Roberts; garret fitzgerald
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition.
The American review of respiratory disease 1989;139(1):46-51.
1988: D J Fitzgerald; J Fragetta; garret fitzgerald
Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
The Journal of clinical investigation 1988;82(5):1708-13.
1988: I A Reilly; H R Knapp; garret fitzgerald
Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia.
Journal of clinical pathology 1988;41(11):1163-7.
1988: John A Oates; garret fitzgerald; Robert A Branch; E K Jackson; H R Knapp; L Jackson Roberts
Clinical implications of prostaglandin and thromboxane A2 formation (2).
The New England journal of medicine 1988;319(12):761-7.
1988: John A Oates; garret fitzgerald; Robert A Branch; E K Jackson; H R Knapp; L Jackson Roberts
Clinical implications of prostaglandin and thromboxane A2 formation (1).
The New England journal of medicine 1988;319(11):689-98.
1988: Ryszard Dworski; D F Wendelborn; James R Sheller; garret fitzgerald; L J Roberts
Prostaglandins in Ascaris antigen.
The Journal of allergy and clinical immunology 1988;82(3 Pt 1):484.
1988: P Alessandrini; J McRae; S Feman; garret fitzgerald
Thromboxane biosynthesis and platelet function in type I diabetes mellitus.
The New England journal of medicine 1988;319(4):208-12.
1988: Ake Wennmalm; garret fitzgerald
Excretion of prostacyclin and thromboxane A2 metabolites during leg exercise in humans.
The American journal of physiology 1988;255(1 Pt 2):H15-8.
1988: Ake Wennmalm; A Edlund; B Sevastik; garret fitzgerald
Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication.
Clinical physiology (Oxford, England) 1988;8(3):243-53.
1988: H R Knapp; C Healy; J Lawson; garret fitzgerald
Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men.
Thrombosis research 1988;50(3):377-86.
1988: E K Jackson; F Goto; H D Uderman; R J Workman; W A Herzer; garret fitzgerald; Robert A Branch
Effects of thromboxane synthase inhibitors on renal function.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(2):183-90.
1988: I A Reilly; garret fitzgerald
Aspirin in cardiovascular disease.
Drugs 1988;35(2):154-76.
1988: P G Kühl; J M Bolds; James E Loyd; JR Snapper; garret fitzgerald
Thromboxane receptor-mediated bronchial and hemodynamic responses in ovine endotoxemia.
The American journal of physiology 1988;254(2 Pt 2):R310-9.
1988: J G Harold; R J Siegel; garret fitzgerald; P Satoh; Michael C Fishbein
Differential prostacyclin production by human umbilical vasculature.
Archives of pathology & laboratory medicine 1988;112(1):43-6.
1988: garret fitzgerald; John A Oates; J Nowak
Cigarette smoking and hemostatic function.
American heart journal 1988;115(1 Pt 2):267-71.
1988: D J Fitzgerald; F Catella; L Roy; garret fitzgerald
Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.
Circulation 1988;77(1):142-50.
1987: K L Fisher; garret fitzgerald; R M Lawn
Two polymorphisms in the human lipoprotein lipase (LPL) gene.
Nucleic acids research 1987;15(18):7657.
1987: F Catella; garret fitzgerald
Paired analysis of urinary thromboxane B2 metabolites in humans.
Thrombosis research 1987;47(6):647-56.
1987: D J Fitzgerald; G Mayo; F Catella; S S Entman; garret fitzgerald
Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets.
American journal of obstetrics and gynecology 1987;157(2):325-30.
1987: J Nowak; John Joseph Murray; J A Oates; garret fitzgerald
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.
Circulation 1987;76(1):6-14.
1987: garret fitzgerald
Dipyridamole.
The New England journal of medicine 1987;316(20):1247-57.
1987: D J Fitzgerald; S S Entman; K Mulloy; garret fitzgerald
Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension.
Circulation 1987;75(5):956-63.
1987: M Wennmalm; garret fitzgerald; A Wennmalm
Prostacyclin as neuromodulator in the sympathetically stimulated rabbit heart.
Prostaglandins 1987;33(5):675-91.
1987: Giovanni Ciabattoni; J Maclouf; F Catella; garret fitzgerald; Carlo Patrono
Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.
Biochimica et biophysica acta 1987;918(3):293-7.
1987: J Nowak; M Wennmalm; A Edlund; A Wennmalm; garret fitzgerald
Vascular effects of infused adenosine are not mediated by prostacyclin release in humans.
The American journal of physiology 1987;252(3 Pt 2):H598-604.
1987: garret fitzgerald; F Catella; J A Oates
Eicosanoid biosynthesis in human cardiovascular disease.
Human pathology 1987;18(3):248-52.
1987: I A Reilly; garret fitzgerald
Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
Blood 1987;69(1):180-6.
1987: garret fitzgerald; C Healy; J Daugherty
Thromboxane A2 biosynthesis in human disease.
Federation proceedings 1987;46(1):154-8.
1987: P Alessandrini; J R McRae; S S Feman; garret fitzgerald
Eicosanoid biosynthesis in human diabetes mellitus.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():682-5.
1987: F Catella; John A Lawson; D J Fitzgerald; garret fitzgerald
Analysis of multiple thromboxane metabolites in plasma and urine.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():611-4.
1987: Giovanni Ciabattoni; A H Boss; L Daffonchio; J Daugherty; garret fitzgerald; F Catella; F Dray; Carlo Patrono
Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():598-602.
1987: D J Fitzgerald; J Fragetta; L C Fenelon; garret fitzgerald
Thromboxane synthase inhibition and thromboxane/endoperoxide receptor antagonism in a chronic canine model of coronary thrombosis.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():496-500.
1987: P G Kühl; J M Bolds; James E Loyd; garret fitzgerald
Thromboxane receptor mediated vascular and airway changes in the presence of increased thromboxane biosynthesis in sheep endotoxemia.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():487-90.
1987: A Edlund; garret fitzgerald; B Sevastik; Ake Wennmalm
Leg exercise increases prostacyclin synthesis without activating platelets in both healthy and atherosclerotic humans.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():447-9.
1987: J Nowak; garret fitzgerald
In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():208-11.
1987: J Nowak; John Joseph Murray; garret fitzgerald; C J Wehr; J W Hammon; John A Oates
Eicosanoids and sudden cardiac death.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():20-4.
1987: garret fitzgerald; D J Fitzgerald; John A Lawson; R Murray
Thromboxane biosynthesis and antagonism in humans.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():199-203.
1986: D J Fitzgerald; L Roy; F Catella; garret fitzgerald
Platelet activation in unstable coronary disease.
The New England journal of medicine 1986;315(16):983-9.
1986: F Catella; J Nowak; garret fitzgerald
Measurement of renal and non-renal eicosanoid synthesis.
The American journal of medicine 1986;81(2B):23-9.
1986: F Catella; D Healy; John A Lawson; garret fitzgerald
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(16):5861-5.
1986: P G Kuehl; R B Cotton; garret fitzgerald
Systemic production of prostacyclin and thromboxane A2 does not correlate with patency of the ductus arteriosus in very low birth weight infants.
The Journal of pediatrics 1986;108(6):977-82.
1986: I A Reilly; J B Doran; B Smith; garret fitzgerald
Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Circulation 1986;73(6):1300-9.
1986: J A Lawson; C Patrono; G Ciabattoni; garret fitzgerald
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation.
Analytical biochemistry 1986;155(1):198-205.
1986: I A Reilly; L Roy; garret fitzgerald
Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
British medical journal (Clinical research ed.) 1986;292(6527):1037-9.
1986: H R Knapp; I A Reilly; P Alessandrini; garret fitzgerald
In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
The New England journal of medicine 1986;314(15):937-42.
1986: I A Reilly; garret fitzgerald
Eicosenoid biosynthesis and platelet function with advancing age.
Thrombosis research 1986;41(4):545-54.
1986: C Patrono; G Ciabattoni; Francesco Pugliese; A Pierucci; Ian Blair; garret fitzgerald
Estimated rate of thromboxane secretion into the circulation of normal humans.
The Journal of clinical investigation 1986;77(2):590-4.
1986: D J Fitzgerald; J Doran; E Jackson; garret fitzgerald
Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.
The Journal of clinical investigation 1986;77(2):496-502.
1985: garret fitzgerald; I A Reilly; A K Pedersen
The biochemical pharmacology of thromboxane synthase inhibition in man.
Circulation 1985;72(6):1194-201.
1985: A K Pedersen; garret fitzgerald
The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.
Circulation 1985;72(6):1164-76.
1985: J A Lawson; A R Brash; J Doran; garret fitzgerald
Measurement of urinary 2,3-dinor-thromboxane B2 and thromboxane B2 using bonded-phase phenylboronic acid columns and capillary gas chromatography--negative-ion chemical ionization mass spectrometry.
Analytical biochemistry 1985;150(2):463-70.
1985: L Roy; H R Knapp; Rose Marie Robertson; garret fitzgerald
Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man.
Circulation 1985;71(3):434-40.
1985: A K Pedersen; garret fitzgerald
Preparation and analysis of deuterium-labeled aspirin: application to pharmacokinetic studies.
Journal of pharmaceutical sciences 1985;74(2):188-92.
1985: A K Pedersen; garret fitzgerald
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing.
Clinical pharmacology and therapeutics 1985;37(1):36-42.
1985: M R Goldberg; David Robertson; garret fitzgerald
Prostacyclin biosynthesis and platelet function in autonomic dysfunction.
Neurology 1985;35(1):120-3.
1985: Ian Blair; A R Brash; J Daugherty; garret fitzgerald
Quantitative analysis of leukotriene B4 in human serum.
Advances in prostaglandin, thromboxane, and leukotriene research 1985;15():61-5.
1985: garret fitzgerald; J Lawson; Ian Blair; A R Brash
Analysis of urinary metabolites of thromboxane and prostacyclin by negative-ion chemical-ionization gas chromatography/mass spectrometry.
Advances in prostaglandin, thromboxane, and leukotriene research 1985;15():87-90.
1984: A K Pedersen; garret fitzgerald
Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
The New England journal of medicine 1984;311(19):1206-11.
1984: D J Fitzgerald; L Roy; Rose Marie Robertson; garret fitzgerald
The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans.
Circulation 1984;70(2):297-302.
1984: garret fitzgerald; D J Fitzgerald
Biosynthesis of thromboxane A2 in renovascular hypertension.
JAMA : the journal of the American Medical Association 1984;251(23):3121-2.
1984: garret fitzgerald; J A Oates
Selective and nonselective inhibition of thromboxane formation.
Clinical pharmacology and therapeutics 1984;35(5):633-40.
1984: garret fitzgerald; B Smith; A K Pedersen; A R Brash
Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation.
The New England journal of medicine 1984;310(17):1065-8.
1984: H R Knapp; garret fitzgerald
Hypertensive crisis in prazosin-treated pheochromocytoma.
Southern medical journal 1984;77(4):535-6.
1984: garret fitzgerald
Peripheral presynaptic adrenoreceptor regulation of norepinephrine release in humans.
Federation proceedings 1984;43(5):1379-81.
1984: M L Watson; R P Goodman; J R Gill; R A Branch; A R Brash; garret fitzgerald
Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man.
The Journal of clinical endocrinology and metabolism 1984;58(2):304-8.
1984: A K Pedersen; M L Watson; garret fitzgerald
Inhibition of thromboxane biosynthesis in serum: limitations of the measurement of immunoreactive 6-keto-PGF1 alpha.
Thrombosis research 1984;33(1):99-103.
1984: J A Oates; A Brash; garret fitzgerald
Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man.
Transactions of the American Clinical and Climatological Association 1984;95():157-62.
1983: garret fitzgerald; A R Brash; J A Oates; A K Pedersen
Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man.
The Journal of clinical investigation 1983;72(4):1336-43.
1983: A S Hollister; garret fitzgerald; J H Nadeau; David Robertson
Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines.
The Journal of clinical investigation 1983;72(4):1498-505.
1983: A R Brash; E K Jackson; C A Saggese; J A Lawson; J A Oates; garret fitzgerald
Metabolic disposition of prostacyclin in humans.
The Journal of pharmacology and experimental therapeutics 1983;226(1):78-87.
1983: R D Feldman; L E Limbird; J Nadeau; garret fitzgerald; David Robertson; A J Wood
Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines.
The Journal of clinical investigation 1983;72(1):164-70.
1983: garret fitzgerald; A K Pedersen; C Patrono
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
Circulation 1983;67(6):1174-7.
1983: garret fitzgerald; J A Oates; Jack Hawiger; R L Maas; L J Roberts; J A Lawson; A R Brash
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
The Journal of clinical investigation 1983;71(3):676-88.
1983: garret fitzgerald; R L Maas; J A Lawson; J A Oates; L J Roberts; A R Brash
Aspirin inhibits endogenous prostacyclin and thromboxane biosynthesis in man.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;11():265-6.
1983: A R Brash; E K Jackson; J A Lawson; R A Branch; J A Oates; garret fitzgerald
Quantitative aspects of prostacyclin metabolism in humans.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;11():119-22.
1982: garret fitzgerald
Prostaglandins.
Irish medical journal 1982;75(5):167-71.
1982: E K Jackson; R P Goodman; garret fitzgerald; J A Oates; R A Branch
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
The Journal of pharmacology and experimental therapeutics 1982;221(1):183-7.
1982: Peter J Barnes; garret fitzgerald; C T Dollery
Circadian variation in adrenergic responses in asthmatic subjects.
Clinical science (London, England : 1979) 1982;62(4):349-54.
1982: garret fitzgerald; S Sherry
Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation.
Advances in prostaglandin, thromboxane, and leukotriene research 1982;10():107-72.
1981: garret fitzgerald; A R Brash; P Falardeau; J A Oates
Estimated rate of prostacyclin secretion into the circulation of normal man.
The Journal of clinical investigation 1981;68(5):1272-6.
1981: garret fitzgerald; M Beggan; M I Drury
Sources of referral, costs and length of hospital stay in a teaching hospital: impact of a day care facility.
Irish medical journal 1981;74(9):265-70.
1981: garret fitzgerald; M I Drury
Indices of cost for inpatients in a teaching hospital.
Irish medical journal 1981;74(9):262-4.
1981: garret fitzgerald; R L Maas; R Stein; J A Oates; L J Roberts
Intravenous prostacyclin in thrombotic thrombocytopenic purpura.
Annals of internal medicine 1981;95(3):319-22.
1981: garret fitzgerald; V Hossmann; C T Dollery
Norepinephrine release in essential hypertension.
Clinical pharmacology and therapeutics 1981;30(2):164-71.
1981: V Hossman; A Heinen; H Auel; garret fitzgerald
A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.
Thrombosis research 1981;22(4):481-90.
1981: L B Polish; R A Branch; garret fitzgerald
Digitoxin-quinidine interaction: potentiation during administration of cimetidine.
Southern medical journal 1981;74(5):633-4.
1981: R M Robertson; David Robertson; L J Roberts; R L Maas; garret fitzgerald; G C Friesinger; J A Oates
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
The New England journal of medicine 1981;304(17):998-1003.
1981: garret fitzgerald; J Watkins; C T Dollery
Regulation of norepinephrine release by peripheral alpha 2-receptor stimulation.
Clinical pharmacology and therapeutics 1981;29(2):160-7.
1981: V Hossmann; garret fitzgerald; C T Dollery
Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertension.
Hypertension 1981;3(1):113-8.
1981: garret fitzgerald; David Robertson; A J Wood
Beta-adrenoreceptor down-regulation by dynamic exercise and upright posture in man.
Transactions of the Association of American Physicians 1981;94():310-3.
1980: garret fitzgerald; V Hossmann; W Hummerich; A Konrads
The renin--kallikrein--prostaglandin system: plasma active and inactive renin and urinary kallikrein during prostacyclin infusion in man.
Prostaglandins and medicine 1980;5(6):445-56.
1980: B Allolio; garret fitzgerald; F X Hipp; V Hossmann; R Mies; W Winkelmann
The effect of prostacyclin on pituitary hormone release.
British journal of clinical pharmacology 1980;10(6):626-7.
1980: garret fitzgerald; P Barnes; C A Hamilton; C T Dollery
Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man.
European journal of clinical investigation 1980;10(5):401-6.
1980: garret fitzgerald; C A Hamilton; D H Jones; J L Reid
Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man.
Clinical science (London, England : 1979) 1980;58(5):423-5.
1980: V Hossmann; garret fitzgerald; C T Dollery
Circadian rhythm of baroreflex reactivity and adrenergic vascular response.
Cardiovascular research 1980;14(3):125-9.
1980: M J Brown; C T Dollery; garret fitzgerald; J Watkins; C Zamboulis
No evidence for antagonism of clonidine by naloxone in man [proceedings].
British journal of clinical pharmacology 1980;9(3):302P.
1980: P Barnes; C T Dollery; garret fitzgerald; C A Hamilton
The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings].
British journal of clinical pharmacology 1980;9(1):107P-108P.
1979: garret fitzgerald; V Hossmann; C A Hamilton; J L Reid; D S Davies; C T Dollery
Interindividual variation in kinetics of infused epinephrine.
Clinical pharmacology and therapeutics 1979;26(6):669-75.
1979: I Miyamori; garret fitzgerald; M J Brown; P J Lewis
Prostacyclin stimulates the renin angiotensin aldosterone system in man.
The Journal of clinical endocrinology and metabolism 1979;49(6):943-4.
1979: C N Hensby; garret fitzgerald; L A Friedman; P J Lewis; C T Dollery
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry.
Prostaglandins 1979;18(5):731-6.
1979: C T Dollery; garret fitzgerald; J Watkins
Pre and postsynaptic alpha-receptor agonists and the rate of release of noradrenaline in man [proceedings].
British journal of clinical pharmacology 1979;8(4):396P.
1979: garret fitzgerald
Neurogenic aspects of essential hypertension in man.
Irish journal of medical science 1979;148(9-10):280-9.
1979: garret fitzgerald; M I Drury
One hundred days in a general medical/specialist unit--sources of referral and length of hospital stay.
Irish medical journal 1979;72(8):344-7.
1979: garret fitzgerald; L A Friedman; I Miyamori; J O'Grady; P J Lewis
A double blind placebo controlled crossover study of prostacyclin in man.
Life sciences 1979;25(8):665-72.
1979: D McCarthy; garret fitzgerald; L G O'Connell; J M Waters; D W Watt; F M Stevens; C F McCarthy; M I Drury
Histocompatibility antigens and haemochromatosis in Ireland.
Irish journal of medical science 1979;148(5-6):168-72.
1979: garret fitzgerald; W X Balcavage
Consequences dietary ethanol on permeability and respiration of mitochondria and liver ADH in young and aged rats.
Currents in alcoholism 1979;5():91-100.
1978: garret fitzgerald; M I Drury
HLA identity in juvenile onset diabetes.
Irish journal of medical science 1978;147(12):430-4.
1978: garret fitzgerald
Hypertensive response to labetalol in phaeochromocytoma.
Lancet 1978;1(8076):1259.
1977: garret fitzgerald; M I Drury
Paracetemol poisoning--a brief report.
Irish medical journal 1977;70(15):448-9.
1977: garret fitzgerald; C Crowe; M I Drury
Cryoglobulinaemia in Henoch-Schönlein purpura.
British medical journal 1977;2(6083):388.
1976: garret fitzgerald; B Colgan; M I Drury; F X O'Connell
Vovulus of the small bowel in a diabetic patient.
British medical journal 1976;2(6041):945.